Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014

被引：0
|
作者：
Arpan Patel
Suna Yapali
Anna S. F. Lok
机构：
[1] University of Michigan,Division of Gastroenterology and Hepatology
[2] University of Michigan Health System,Division of Gastroenterology and Hepatology
来源：
Hepatology International | 2016年 / 10卷
关键词：
Hepatitis B virus; Hepatitis; Liver failure; Chemotherapy; Antiviral therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：139 / 146
页数：7
相关论文
共 50 条
  • [31] Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
    Liu, Chun-Jen
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 316 - 326
  • [32] Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection
    Pritchard, Haley
    Hwang, Jessica P.
    Angelidakis, Georgios
    Yibirin, Marcel
    Wang, Lan
    Miller, Ethan
    Torres, Harrys A.
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (05) : 844 - 848
  • [33] Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy
    Tamori, A.
    Abiru, S.
    Enomoto, H.
    Kioka, K.
    Korenaga, M.
    Tani, J.
    Enomoto, M.
    Sugiyama, M.
    Masaki, T.
    Kawada, N.
    Yatsuhashi, H.
    Nishiguchi, S.
    Mizokami, M.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 608 - 611
  • [34] Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review
    Tavakolpour, Soheil
    Alavian, Seyed Moayed
    Sali, Shahnaz
    HEPATITIS MONTHLY, 2016, 16 (04)
  • [35] Management of the risk of hepatitis B virus reactivation in patients receiving immunosuppressive and immunomodulatory agents in internal medicine: Data from the REACTI-B survey and proposal for a management algorithm
    Terrier, B.
    Pol, S.
    Thibault, V.
    Gottenberg, J-E
    Cacoub, P.
    REVUE DE MEDECINE INTERNE, 2012, 33 (01): : 4 - 12
  • [36] Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib
    Wang, Sz-Tsan
    Tseng, Chih-Wei
    Hsu, Chia-Wen
    Tung, Chien-Hsueh
    Huang, Kuang-Yung
    Lu, Ming-Chi
    Lai, Ning-Sheng
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (11) : 1362 - 1369
  • [37] Characteristics, Prevention, and Management of Hepatitis B Virus (HBV) Reactivation in HBV-Infected Patients Who Require Immunosuppressive Therapy
    Choi, Jonggi
    Lim, Young-Suk
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S778 - S784
  • [38] Incidence and antiviral response of hepatitis C virus reactivation in lupus patients undergoing immunosuppressive therapy
    Chen, M-H
    Chen, M-H
    Tsai, C-Y
    Chou, C-T
    Lin, H-Y
    Huang, D-F
    Huang, Y-H
    LUPUS, 2015, 24 (10) : 1029 - 1036
  • [39] Impact of the Timing of Hepatitis B Virus Identification and Anti-Hepatitis B Virus Therapy Initiation on the Risk of Adverse Liver Outcomes for Patients Receiving Cancer Therapy
    Hwang, Jessica P.
    Suarez-Almazor, Maria E.
    Cantor, Scott B.
    Barbo, Andrea
    Lin, Heather Y.
    Ahmed, Sairah
    Chavez-MacGregor, Mariana
    Donato-Santana, Christian
    Eng, Cathy
    Ferrajoli, Alessandra
    Fisch, Michael J.
    McLaughlin, Peter
    Simon, George R.
    Rondon, Gabriela
    Shpall, Elizabeth J.
    Lok, Anna S.
    CANCER, 2017, 123 (17) : 3367 - 3376
  • [40] Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor
    Guan-Min Lai
    Sheng-Lei Yan
    Cheng-Shyong Chang
    Chien-Yu Tsai
    World Journal of Gastroenterology, 2013, (08) : 1318 - 1321
12345